The catechol-O-methyltransferase inhibitor tolcapone modulates alcohol consumption and impulsive choice in alcohol use disorder.

Autor: Coker AR; Department of Neurology, University of California, San Francisco, CA, USA. allison.coker@ucsf.edu., Weinstein DN; Department of Neurology, University of California, San Francisco, CA, USA., Vega TA; Department of Neurology, University of California, San Francisco, CA, USA.; Department of Neurology, VA Northern California Health Care System, Mather, CA, USA., Miller CS; Department of Neurology, University of California, San Francisco, CA, USA., Kayser AS; Department of Neurology, University of California, San Francisco, CA, USA.; Department of Neurology, VA Northern California Health Care System, Mather, CA, USA., Mitchell JM; Department of Neurology, University of California, San Francisco, CA, USA.; Department of Psychiatry, University of California, San Francisco, CA, USA.

Publikováno v: Psychopharmacology [Psychopharmacology (Berl)] 2020 Oct; Vol. 237 (10), pp. 3139-3148. Date of Electronic Publication: 2020 Jul 02.